Literature DB >> 32043289

Family caregivers' lived experiences of caring for epidermolysis bullosa patients: A phenomenological study.

Yeh-Hsun Wu1, Fan-Ko Sun2, Pei-Yu Lee3.   

Abstract

AIMS AND
OBJECTIVES: To explore the lived experiences of family caregivers of epidermolysis bullosa (EB) patients.
BACKGROUND: Patients with EB need long-term care. Their family experiences physical and mental stress while proving that care. However, very little research has explored the family caregivers' actual lived experiences when caring for EB patients.
DESIGN: This is a qualitative research using the phenomenological approach.
METHODS: Data were collected with the assistance of the Taiwan Foundation for Rare Disorders (TFRD). Interviews were conducted between 2015 and 2017 with primary family caregivers (n = 10) who had cared for EB patients for at least five years. Data were analysed using Colaizzi's (1978) seven-step phenomenological method. COREQ reporting guidelines were utilised.
RESULTS: Four themes and eleven subthemes emerged after data analysis: (a) transformation and helplessness: changing expectations and helplessness associated with the rare, unknown disease; (b) mother's responsibility: mothers loving and protecting their children, surviving through adversity and challenges and self-experiencing a child's pain; (c) physical and mental fatigue experienced by the whole family: physical and mental exhaustion, and unbalanced lives; and (d) adjustment and social support: providing mutual assistance to mitigate adversity, hopeful search for treatments, the importance of patient associations and rare disease foundations, and social assistance requirements.
CONCLUSION: Family caregivers experience many challenges when caring for EB patients and experience substantial stress and overwhelming burdens. Consequently, they would benefit greatly from various support systems to reduce the burden of caring for EB patients. RELEVANCE TO CLINICAL PRACTICE: Healthcare professionals can use the findings from this study to understand the circumstances faced by family caregivers and tailor care and education specifically to support each family's financial, social and household needs, thereby helping them reduce the stress of caring for EB patients.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  epidermolysis bullosa; family caregiver; lived experiences; phenomenology

Year:  2020        PMID: 32043289     DOI: 10.1111/jocn.15209

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  6 in total

1.  Mental health care for rare disease in the UK - recommendations from a quantitative survey and multi-stakeholder workshop.

Authors:  Rosa Spencer-Tansley; Nick Meade; Farhana Ali; Amy Simpson; Amy Hunter
Journal:  BMC Health Serv Res       Date:  2022-05-14       Impact factor: 2.908

2.  Women Caring for Husbands Living with Parkinson's Disease: A Phenomenological Study Protocol.

Authors:  Dawn R White; Patrick Albert Palmieri
Journal:  J Pers Med       Date:  2022-04-20

3.  Psychiatric distress in family caregivers of patients with COVID-19.

Authors:  Mehdi Jafari-Oori; Abbas Ebadi; Seyyed Tayeb Moradian; Mojtaba Jafari; Manijeh Dehi; Fatemeh Ghasemi Fard
Journal:  Arch Psychiatr Nurs       Date:  2021-07-12       Impact factor: 2.218

4.  It's more than just lubrication of the skin: parents' experiences of caring for a child with ichthyosis.

Authors:  Elisabeth Daae; Kristin Billaud Feragen; Jan C Sitek; Charlotte von der Lippe
Journal:  Health Psychol Behav Med       Date:  2022-04-05

5.  Assessing the quality of life in the families of patients with epidermolysis bullosa: The mothers as main caregivers.

Authors:  Fatemeh Chogani; Mohammad Mahdi Parvizi; Dedee F Murrell; Farhad Handjani
Journal:  Int J Womens Dermatol       Date:  2021-08-26

Review 6.  Children with a rare congenital genetic disorder: a systematic review of parent experiences.

Authors:  Charlotte von der Lippe; Ingrid Neteland; Kristin Billaud Feragen
Journal:  Orphanet J Rare Dis       Date:  2022-10-17       Impact factor: 4.303

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.